Drug Class: Growth Hormone Secretagogue Blend
Composition:
- Ipamorelin 5 mg
- Tesamorelin 5 mg
Dosage: 10 mg/vial
Form: Lyophilized Powder
Unit: 2 mL Vial
Brand: Dragon Pharma
For Subcutaneous Injection
Laboratory Test: View Lab Report
For the discerning athlete who demands the pinnacle of peptide technology, combining individual compounds can yield remarkable results. However, Dragon Pharma has engineered the ultimate solution: a pre-blended, precision-dosed vial containing Ipamorelin 5 mg and Tesamorelin 5 mg. This is not just another growth hormone secretagogue; it is a strategically formulated stack that leverages the unique strengths of two of the most advanced peptides available. Ipamorelin provides the clean, selective pulse, while Tesamorelin offers the sustained, targeted action—particularly against stubborn visceral fat. This Dragon Pharma GH secretagogue stack represents the next evolution in performance enhancement, offering unparalleled fat loss, quality muscle preservation, and deep recovery for bodybuilders and athletes who settle for nothing less than the best.
This powerful combination works through complementary mechanisms to produce a superior physiological response compared to either peptide alone. Ipamorelin is a growth hormone-releasing peptide (GHRP) that stimulates a robust, natural GH pulse, while Tesamorelin is a growth hormone-releasing hormone (GHRH) analog that provides a sustained signal for GH release. Together, they create a powerful synergistic effect:
This product arrives as a single 10mg lyophilized powder blend (5mg Ipamorelin + 5mg Tesamorelin) in a 2mL vial. Reconstitute with Bacteriostatic Water.
Reconstitution Example: Adding 2mL of diluent creates a concentration of 5mg/mL total peptide, meaning each 1mL (100 unit mark on an insulin syringe) contains 2.5mg Ipamorelin and 2.5mg Tesamorelin.
Standard Dosing Protocol:
Injections are performed subcutaneously and should be administered on an empty stomach, ideally 2-3 hours after your last meal. For those seeking more frequent pulses, a twice-daily protocol (upon waking and before bed) can be used at a lower dose per injection (e.g., 500-750 mcg).
The Dragon Pharma Ipamorelin/Tesamorelin blend is the cornerstone of any cutting or recomping protocol. Its ability to shred fat while preserving muscle makes it incredibly versatile when stacked with other compounds.
This blend is renowned for its excellent safety and tolerability profile. Side effects are generally mild and much less common than with older GHRPs:
The clinical profile of Tesamorelin is well-established for its safety and efficacy in reducing visceral fat, providing a strong foundation for its use in this advanced blend.
Creating a stable, pre-mixed peptide blend requires exceptional manufacturing precision. Dragon Pharma's advanced lyophilization technology ensures that both the Ipamorelin and Tesamorelin molecules remain stable, pure, and perfectly dosed within the same vial. This eliminates the need to purchase and mix two separate vials, guaranteeing consistency, sterility, and convenience. When you choose to buy Ipamorelin/Tesamorelin USA from Dragon Pharma, you are investing in a product where scientific formulation meets uncompromising quality control, delivering a synergistic effect that is greater than the sum of its parts.
Name: Ipamorelin and Tesamorelin Blend
Drug Class: Growth Hormone Secretagogue (GHRP & GHRH Analog)
Other common names and terms: Ipamorelin/Tesamorelin Stack, GH-Releasing Blend
Active Life: Ipamorelin: ~2 hours; Tesamorelin: ~30 minutes (effects are prolonged)
Detection Time: Not applicable for standard athletic testing
Chemical Structure: Ipamorelin (Pentapeptide), Tesamorelin (Modified GRF 1-44)
Common Doses: 500-1000 mcg of each peptide, typically once daily
Blood pressure: No negative effect; may have a positive regulatory effect
Acne: Rare, due to increased IGF-1
Water retention: Minimal to none
Aromatisation: Does not aromatize
Liver toxicity: Not hepatotoxic
Decrease HPTA function: Does not suppress the HPTA axis
This blend is uniquely potent for fat loss due to the specific action of Tesamorelin. While other GHRHs like Mod GRF 1-29 provide a general GH boost, Tesamorelin has a demonstrated clinical preference for reducing visceral abdominal fat. When combined with the clean, selective pulse of Ipamorelin, it creates a stack that is specifically engineered for dramatic improvements in body composition and midsection definition.
Absolutely. This is one of its primary advantages. Ipamorelin is the most selective GHRP, meaning it has a strong affinity for GH release with minimal impact on other hormones like cortisol, prolactin, and appetite-stimulating pathways. If you experienced unwanted hunger with GHRP-6 or other sides with GHRP-2, this Ipamorelin-based blend is the ideal solution.
Subjective feelings of improved sleep and recovery are often reported within the first 1-2 weeks. Visible fat loss, particularly a tightening and leaning out of the abdominal region, typically becomes noticeable after 4-6 weeks of consistent use. The most dramatic changes in visceral fat reduction and vascularity accumulate over a 12-week cycle or longer.
For this specific blend, yes. The long-acting nature of Tesamorelin's effects on GH pulsatility, combined with the powerful synergistic pulse from Ipamorelin, makes a single bedtime injection highly effective. This protocol also significantly reduces the risk of desensitization and is far more convenient. For those seeking to maximize pulses, a twice-daily protocol is an option, but once daily is the standard and effective approach for this particular stack.
Due to the specific and well-tolerated nature of both Ipamorelin and Tesamorelin, longer cycles are not only possible but often recommended to achieve the full benefits, especially for visceral fat loss. Cycles of 16-24 weeks are common. A break of 4-8 weeks between long cycles is sufficient, as the selective nature of these peptides minimizes the risk of desensitization that plagues other GHRPs.
Please log in to write Ipamorelin 5 mg/Tesamorelin 5 mg review.
For Intramuscular Injection
Composition:
- Testosterone Propionate 42 mg
- Testosterone Phenylropionate 84 mg
- Testosterone Isocaproate 84 mg
- Testosterone Decanoate 140 mg
Mixed Dosage: 350 mg/1 mL
Unit: 10 mL Multidose Vial
Manufactured by Kalpa Pharmaceuticals